Voltammetric determination of flufenamic acid and adsorption studies with biochar in the absence / presence of cetyltrimethylammonium bromide.

In this article, a novel method for the determination of Flufenamic acid (FFA, pharmaceutical pollutant) is presented based on voltammetric oxidation at a carbon paste electrode (CPE) in-situ modified with cetyltrimethylammonium bromide (CTAB). The experimentally proved "erosion effect" of this surfactant enhanced the sensitivity of detection in the SWASV mode allowing us to quantify the analyte down to the low nanomolar level (with a LOD of 5.5 × 10 mol L FFA).

Separation of Anionic Chlorinated Dyes from Polluted Aqueous Streams Using Ionic Liquids and Their Subsequent Recycling.

The effect of ionic liquids on the separation of chlorinated anionic dyes such as Mordant Blue 9 (MB9) or Acid Yellow 17 (AY17) via ion exchange has been investigated in model aqueous solutions that simulate wastewater from the textile dyeing industry. The effect of ionic liquids chemical nature on the separation efficiency of mentioned dyes has been compared. It was found that especially ionic liquid based on quaternary ammonium salts comprising two or three long alkyl chains bound to the quaternary ammonium nitrogen (typically benzalkonium chloride or Aliquat 336) are very effective for the separation of both studied MB9 and AY17 from aqueous solution.

Application of Raney Al-Ni Alloy for Simple Hydrodehalogenation of Diclofenac and Other Halogenated Biocidal Contaminants in Alkaline Aqueous Solution under Ambient Conditions.

Raney Al-Ni contains 62% of NiAl and 38% NiAl crystalline phases. Its applicability has been studied within an effective hydrodehalogenation of hardly biodegradable anti-inflammatory drug diclofenac in model aqueous concentrates and, subsequently, even in real hospital wastewater with the aim of transforming them into easily biodegradable products. In model aqueous solution, complete hydrodechlorination of 2 mM aqueous diclofenac solution (0.

Humoral immunity in dually vaccinated SARS-CoV-2-naïve individuals and in booster-vaccinated COVID-19-convalescent subjects.

Background: The immune response to COVID-19-vaccination differs between naïve vaccinees and those who were previously infected with SARS-CoV-2. Longitudinal quantitative and qualitative serological differences in these two distinct immunological subgroups in response to vaccination are currently not well studied.

Methods: We investigate a cohort of SARS-CoV-2-naïve and COVID-19-convalescent individuals immediately after vaccination and 6 months later.